Skip to content

HKPD

Cellyan Biotechnology Ltd.

NASDAQ · Healthcare · Medical - Pharmaceuticals · HK

$2.19
+0.44%
Ask drillr
  • Oct 21, 2026, 12:00 UTC

    Cellyan Biotechnology announced a 1-for-20 reverse stock split of its Class A and Class B ordinary shares, effective at the market opening on October 26, 2026.